Jeff Leek

Jeff Leek

Vice President, Chief Data Officer, and Professor at Fred Hutch
Seattle, Washington, United States

Jeff Leek is Co-CEO and Co-Founder at Synthesize Bio. He is Vice President, Chief Data Officer, and Professor at Fred Hutch. He was Co-Founder at Streamline Data Science and Professor of Biostatistics and Oncology at Johns Hopkins Bloomberg School of Public Health. He was Co-Founder at Problem Forward Data Science. He was named to Time AI 100.

Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model

Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.

Leading $10M Seed Funding Supports Synthesize Bio's AI-Powered GEM-1 Model Transforming Generative Genomics

The future of biotech is being shaped by AI-powered reasoning machines, exemplified by Synthesize Bio's $10M Seed funding led to develop GEM-1, a generative genomics model simulating gene expression as accurately as lab experiments. This technology enables researchers to conduct more innovative and cost-effective life science R&D, moving from bottlenecks to breakthroughs.

Organizations

See all 5
  • Fred Hutch logo
    Fred Hutch Vice President, Chief Data Officer, and Professor 2022–present · current
  • Synthesize Bio logo
    Synthesize Bio Co-founder, Co-CEO 2023–present · current
  • Johns Hopkins Bloomberg School of Public Health Assistant Professor of Biostatistics, Professor of Biostatistics and Oncology 2018–2022, Associate Professor of Biostatistics and Oncology 2014–2018 · current

Education

Online